GB2360216A — Inhaler
Assigned to AstraZeneca UK Ltd · Expires 2001-09-19 · 25y expired
What this patent protects
An inhaler for delivery by inhalation of a medicament from the canister which is compressible to deliver a dose of medicament. The inhaler comprises a housing for holding a canister 2 having a generally cylindrical body 3 with the cylindrical axis of the body 3 in predetermined d…
USPTO Abstract
An inhaler for delivery by inhalation of a medicament from the canister which is compressible to deliver a dose of medicament. The inhaler comprises a housing for holding a canister 2 having a generally cylindrical body 3 with the cylindrical axis of the body 3 in predetermined direction and a loading mechanism for loading a resilient loading element 7 which is arranged, when loaded, to bias compression of the canister 2. The loading mechanism comprises a loading member 8 engaging the resilient loading element 7 and two contact members 9 movable relative to the housing in a movement direction orthogonal to said predetermined direction and arranged to drive the loading member 8 to load the resilient loading element 7, through a cam arrangement between the contact member 8. The cam arrangement may allow for the ratio of the amount of driven movement of the loading member 8 to the amount of mount of the contact members 9 to be non-linear, preferably reducing over the driven movement to compensate for the increasing resistance by the resilient loading element.
Drugs covered by this patent
- Remodulin (TREPROSTINIL) · United Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.